Tocilizumab use in patients with moderate to severe COVID‐19: A retrospective cohort study
Sridhar Chilimuri(Montefiore Health System), Suresh Kumar Nayudu(Icahn School of Medicine at Mount Sinai), Jairo Tejada(Icahn School of Medicine at Mount Sinai), Haozhe Sun(Icahn School of Medicine at Mount Sinai), Peter Lao(Mount Sinai Health System), Myroslava Sharabun(Mount Sinai Health System), Alla Yugay(Icahn School of Medicine at Mount Sinai), Nikhitha Mantri(Montefiore Health System), Ahmed Alemam(Icahn School of Medicine at Mount Sinai), Elona Shehi(Icahn School of Medicine at Mount Sinai), Kyoung‐Sil Kang(Mount Sinai Health System), Lawrence R. Schiller(Universität Innsbruck)
Cited by 18
Related Papers
Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
|Case Reports in Gastroenterology|2015|1.4k
Vitamin D deficiency is associated with mortality in the medical intensive care unit
|Critical Care|2011|182
Predictors of Mortality in Adults Admitted with COVID-19: Retrospective Cohort Study from New York City
|Western Journal of Emergency Medicine|2020|108
Non-Alcoholic Fatty Pancreatic Disease: A Review of Literature
|Gastroenterology Research|2016|104